GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (STU:7CA) » Definitions » Research & Development

Camurus AB (STU:7CA) Research & Development : €66.2 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Camurus AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Camurus AB's Research & Development for the three months ended in Sep. 2024 was €14.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was €66.2 Mil.

Camurus AB Research & Development Historical Data

The historical data trend for Camurus AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Research & Development Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.78 23.46 37.84 43.09 57.01

Camurus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.48 20.57 15.91 15.37 14.34

Camurus AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €66.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB  (STU:7CA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Camurus AB Research & Development Related Terms

Thank you for viewing the detailed overview of Camurus AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (STU:7CA) » Definitions » Research & Development
Comparable Companies
OSTO:BIOA B OSTO:CALTX OSTO:GENO OSTO:VICO OSTO:EGTX OSTO:HNSA OSTO:IBT B OSTO:FLUO OSTO:BINV OSTO:XSPRAY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CAMRF:USA CAMX:Sweden CAMXs:UK 0RD1:UK
Address
Ideon Science Park, Lund, SWE, SE-223 70
Website
https://www.camurus.com
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines